Search alternatives:
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
621
-
622
-
623
-
624
-
625
-
626
ISO decreases σ<sub>period</sub> for cardiomyocytes cultivated on PDMS 1:20 and tends to stabilize the rate of contraction.
Published 2015“…One minute after adding ISO (100 nM) on PDMS 1:20 substrates. Pharmacological sympathetic stimulation appears to decrease the number of activation sites (from 4 sites pre-ISO to 2 sites after ISO).…”
-
627
Statistically significant correspondence between human psoriasis and mouse psoriasiform phenotypes: Proportion of psoriasiform-increased to psoriasiform-decreased transcripts.
Published 2011“…<p>Genes significantly increased or decreased in human psoriasis were identified and the expression of orthologous genes was studied in the K5-Tie2 phenotype (A and B), the IMQ phenotype (C and D), the K14-AREG phenotype on ear skin (E and F), the K14-AREG phenotype on tail skin (G and H), the K5-Stat3C phenotype (I and J), and the K5-TGFβ1 phenotype (K and L). …”
-
628
Phospho-ERK level is decreased in 3D spheroids.
Published 2014“…(<b>C</b>) At 100,000 cells per spheroid, HeyA8 cells treated with SDF-1α and PMA showed activation of phospho-ERK levels. (**, P <0.005 vs Adh, 1-way ANOVA). …”
-
629
-
630
-
631
-
632
MCF-7 cells were treated with 0, 10, or 20 μM of Peptide 1 or Peptide 2 for 48h.
Published 2020Subjects: -
633
-
634
-
635
-
636
-
637
-
638
-
639
-
640
The MCF-7 and/or MDA-MB-468 cells were treated with or without 10 μM Peptide 1 for 48h.
Published 2020Subjects: